Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • User Manual for Measuring Parkinson's Protein Could Speed Research

    User Manual for Measuring Parkinson's Protein Could Speed Research

    MJFF-funded consortium publishes on how best to test for the protein alpha-synuclein in blood and spinal fluid, which could lead to more accurate and replicable results.
    Learn more
  • A Personal (and Professional) Mission to Cure Parkinson's

    A Personal (and Professional) Mission to Cure Parkinson's

    Jonathan Silverstein, health care venture capitalist, was diagnosed with GBA-associated Parkinson's that has deepened his motivation to find a cure.
    Learn more
  • Diabetes Drug Trial Results Lay Foundation for Further Investigation

    Diabetes Drug Trial Results Lay Foundation for Further Investigation

    Recently published results of a Phase II trial evaluating exenatide in Parkinson's disease indicate potential benefit, but more research is needed.
    Learn more
  • PPMI Data Shows Brain Changes Linked to Parkinson's Progression

    PPMI Data Shows Brain Changes Linked to Parkinson's Progression

    Two studies using data from the MJFF-led Parkinson's Progression Markers Initiative point to brain imaging scans that could help advance drug trials.
    Learn more
  • Can Dogs Help Diagnose Parkinson's Disease?

    Can Dogs Help Diagnose Parkinson's Disease?

    A new study was launched to investigate if man's best friend can play a role in PD diagnosis.
    Learn more
  • MJFF Advancing Nilotinib in Parkinson's Clinical Trial

    MJFF Advancing Nilotinib in Parkinson's Clinical Trial

    The FDA has approved a Phase IIa clinical trial to test the safety and tolerability of nilotinib (Tasigna) in PD.
    Learn more
  • Acquisition May Speed PD Therapies to Meet Unmet Needs

    Acquisition May Speed PD Therapies to Meet Unmet Needs

    Biotech acquisition could help speed PD therapeutic development.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year